Analysts expect Recursion Pharmaceuticals, Inc. to report revenue of 12.55 M for Q3 26, against a range of 11.93 M to 13.16 M. The most recent reported quarter, Q2 26, came in at 7.30 M, a 31.2% miss against the 10.61 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 26.08 M | 4.51 M | 14.82 M | 19.10 M | 4.98 M | 35.35 M | 6.30 M | 7.30 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 20.88 M | 15.37 M | 16.32 M | 16.57 M | 17.31 M | 27.08 M | 17.12 M | 11.39 M | 13.16 M | 14.95 M | 12.44 M | 16.37 M | 18.17 M | 36.43 M | 21.12 M | 24.52 M | ||||||||||
| Low Estimate | 18.17 M | 14.35 M | 14.53 M | 15.59 M | 15.45 M | 23.76 M | 15.79 M | 9.82 M | 11.93 M | 13.44 M | 11.44 M | 14.29 M | 16.35 M | 33.87 M | 19.80 M | 20.28 M | ||||||||||
| Consensus Estimate | 19.52 M | 14.86 M | 15.43 M | 16.08 M | 16.38 M | 25.42 M | 16.46 M | 10.61 M | 12.55 M | 14.19 M | 11.94 M | 15.33 M | 17.26 M | 35.15 M | 20.46 M | 22.40 M |
Analysts expect Recursion Pharmaceuticals, Inc. to report earnings per share of -0.23 for Q3 26, against a range of -0.25 to -0.21. The most recent reported quarter, Q2 26, came in at -0.25 , in line with the -0.25 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.34 | -0.53 | -0.50 | -0.41 | -0.36 | -0.21 | -0.22 | -0.25 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.32 | -0.39 | -0.44 | -0.32 | -0.37 | -0.27 | -0.26 | -0.23 | -0.21 | -0.19 | -0.20 | -0.21 | -0.18 | -0.16 | -0.21 | -0.19 | ||||||||||
| Low Estimate | -0.38 | -0.47 | -0.54 | -0.36 | -0.41 | -0.31 | -0.30 | -0.27 | -0.25 | -0.23 | -0.24 | -0.23 | -0.22 | -0.18 | -0.23 | -0.21 | ||||||||||
| Consensus Estimate | -0.35 | -0.43 | -0.49 | -0.34 | -0.39 | -0.29 | -0.28 | -0.25 | -0.23 | -0.21 | -0.22 | -0.22 | -0.20 | -0.17 | -0.22 | -0.20 |
Pull Wall Street consensus for Recursion Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RXRX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RXRX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RXRX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();